So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Thang điểm Đánh giá Toàn diện của Bệnh nhân về Sự Thay đổi (PGIC)× | Thang đo suy giảm chức năng Sheehan (SDS)× | |
|---|---|---|
| Lĩnh vực | Tâm lý học lâm sàng | Tâm lý học lâm sàng |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 1976 | 1983 |
| Người khởi xướng≠ | William Guy | David V. Sheehan |
| Loại≠ | Self-report single-item rating | Self-report questionnaire |
| Công trình gốc≠ | Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, US Department of Health, Education, and Welfare. link ↗ | Sheehan, D. V. (1983). The Anxiety Disease. New York: Scribner. ISBN: 9780684183078 |
| Tên gọi khác | PGIC, Patient Global Impression of Change Scale | SDS, Sheehan Disability Scale |
| Liên quan | 4 | 4 |
| Tóm tắt≠ | The Patient Global Impression of Change is a single-item, seven-point rating scale asking patients to report their overall impression of change since treatment initiation. Originally published by William Guy in the ECDEU Assessment Manual in 1976, the PGIC has become a standard co-primary endpoint in clinical trials assessing treatment efficacy. The scale is endorsed by the FDA as a patient-reported outcome measure for demonstrating clinical benefit. Despite its simplicity, the PGIC captures patients' holistic perception of improvement—integrating symptom reduction, functional recovery, and subjective well-being. | The Sheehan Disability Scale is a brief three-item self-report measure designed by David V. Sheehan to assess functional impairment across work/school, social life, and family life domains in psychiatric and medical disorders. First described in Sheehan's 1983 book 'The Anxiety Disease' and validated in multiple studies since, the SDS quantifies the degree to which a patient's illness interferes with major life domains. It is widely used in psychiatric research and clinical practice to assess the functional impact of depression, anxiety, ADHD, and other conditions, complementing symptom severity measures by capturing real-world impairment. |
| ScholarGateBộ dữ liệu ↗ |
|
|